Knowledge @lert for Thursday 23rd August
UK government’s preparations for a no deal scenario – GOV.UK
The government has today published guidance on how to prepare for Brexit if there’s no deal. Guidance relating to blood products, regulating medicines and medical equipment includes:
-
Ensuring blood and blood products are safe if there’s no Brexit deal
-
How medicines, medical devices and clinical trials would be regulated if there’s no Brexit deal
-
Submitting regulatory information on medical products if there’s no Brexit deal
-
Quality and safety of organs, tissues and cells if there’s no Brexit deal
NHS e-Referral Service
NHS Digital has announced that all acute hospital trusts across the north of England have successfully switched to receiving 100% of referrals for first outpatient appointments through the NHS e-Referral Service (e-RS). A total of 47 hospitals and 2,479 GP practices have now switched. From 1 October 2018, trusts will only take electronic referrals from GPs.
Asthma audit development
The Health Quality Improvement Partnership has published Asthma Audit Development Project: final report 2018. This report provides information on the activities and conclusions of phase 2 of the Asthma Audit Development Project.
Reward in the NHS newsletter now available – NHS Employers
Download and share the August 2018 edition of our pay and reward newsletter featuring the latest news, developments and expert insight.
Embedding quality improvement skills with Pedro Delgado – NHS Improvement
We have produced a short series of videos with Pedro Delgado the Head of Europe and Latin America region for the Institute for Healthcare Improvement (IHI), to help you build improvement capability and embed quality improvement skills in your organisation.
NICE guideline
NG103 | Flu vaccination: increasing uptake |
Interventional procedures guidance
IPG624 | Sutureless aortic valve replacement for aortic stenosis |
IPG625 | Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia |
Technology appraisal guidance
TA538 | Dinutuximab beta for treating neuroblastoma |
Statistics
- National Reporting and Learning System (NRLS) monthly report, England – August 2017 to July 2018
- Community Life Survey, England – 2017 to 2018